Physician profile
Ekta Patel
NPI 1568992477
$2,481.58
in general payments reported to CMS, 2019-2025
15 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 79% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $41.71 · 2023: $107 · 2024: $684 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,183 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,182.67 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $590.65 | 2023-2025 | Xiidra, Miebo, Envista Mx60 Iol |
| Regeneron Healthcare Solutions, INC. | $288.72 | 2022-2025 | Eylea Hd, Eylea |
| Sun Pharmaceutical Industries INC. | $260.60 | 2022-2025 | Cequa |
| Rxsight INC | $248.03 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Alcon Vision LLC | $244.07 | 2021-2023 | Hydrus Microstent |
| Ani Pharmaceuticals, INC. | $170.00 | 2024 | Purified Cortrophin Gel |
| Abbvie INC. | $149.80 | 2023-2025 | |
| Astellas Pharma US INC | $128.00 | 2025 | Izervay |
| Carl Zeiss Meditec USA, INC. | $126.44 | 2025 | Veracity Surgical |
| Carl Zeiss Meditec, INC. | $125.29 | 2025 | Veracity Surgical |
| Dompe US, INC. | $51.70 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $47.50 | 2024-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $19.68 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $19.12 | 2025 | |
| Novartis Pharmaceuticals Corporation | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ekta Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.